REGN vs. SPY
Compare and contrast key facts about Regeneron Pharmaceuticals, Inc. (REGN) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: REGN or SPY.
Correlation
The correlation between REGN and SPY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
REGN vs. SPY - Performance Comparison
Key characteristics
REGN:
-1.48
SPY:
-0.09
REGN:
-2.13
SPY:
-0.02
REGN:
0.74
SPY:
1.00
REGN:
-0.76
SPY:
-0.09
REGN:
-1.46
SPY:
-0.45
REGN:
27.12%
SPY:
3.31%
REGN:
26.80%
SPY:
15.87%
REGN:
-91.81%
SPY:
-55.19%
REGN:
-52.22%
SPY:
-17.32%
Returns By Period
In the year-to-date period, REGN achieves a -19.39% return, which is significantly lower than SPY's -13.53% return. Over the past 10 years, REGN has underperformed SPY with an annualized return of 2.66%, while SPY has yielded a comparatively higher 11.25% annualized return.
REGN
-19.39%
-16.55%
-43.31%
-38.72%
3.09%
2.66%
SPY
-13.53%
-13.08%
-11.25%
-0.26%
17.01%
11.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
REGN vs. SPY — Risk-Adjusted Performance Rank
REGN
SPY
REGN vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
REGN vs. SPY - Dividend Comparison
REGN's dividend yield for the trailing twelve months is around 0.15%, less than SPY's 1.42% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals, Inc. | 0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.42% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
REGN vs. SPY - Drawdown Comparison
The maximum REGN drawdown since its inception was -91.81%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for REGN and SPY. For additional features, visit the drawdowns tool.
Volatility
REGN vs. SPY - Volatility Comparison
Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 11.68% compared to SPDR S&P 500 ETF (SPY) at 9.29%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.